Description
Listing and trading of 1,55,10,000 equity shares of Integrated Proteins Ltd issued on preferential basis pursuant to conversion of warrants, with lock-in until June 30, 2026.
Summary
BSE has approved the listing of 1,55,10,000 new equity shares of Integrated Proteins Ltd (Scrip Code: 519606) issued to non-promoters on a preferential basis pursuant to conversion of warrants. The shares will commence trading on December 18, 2025, and are subject to a lock-in period until June 30, 2026.
Key Points
- 1,55,10,000 equity shares of Rs. 10/- each issued at a premium of Rs. 1.25/-
- Issue price: Rs. 11.25 per share
- Issued to non-promoters on preferential basis pursuant to warrant conversion
- Distribution numbers: 3203601 to 18713600
- Date of allotment: August 7, 2025
- ISIN: INE177M01013
- Shares rank pari-passu with existing equity shares
- All shares subject to lock-in until June 30, 2026
Regulatory Changes
No regulatory changes introduced.
Compliance Requirements
- Trading members are informed of the new securities listing
- Lock-in restrictions apply to all 1,55,10,000 shares until June 30, 2026
- Shares cannot be transferred or traded during the lock-in period
Important Dates
- Notice Date: December 17, 2025
- Date of Allotment: August 7, 2025
- Trading Commencement: December 18, 2025
- Lock-in Expiry: June 30, 2026
Impact Assessment
This is a routine listing notice with minimal market impact. The preferential allotment increases the paid-up capital of Integrated Proteins Ltd by approximately 15.51 crore shares. The lock-in period ensures these shares remain restricted for approximately 6 months from the trading commencement date, preventing immediate dilution in the market. The warrant conversion at Rs. 11.25 per share indicates existing investor confidence and commitment to the company.
Impact Justification
Routine listing notice for preferential allotment to non-promoters. Standard warrant conversion with lock-in period. Limited market-wide impact.